[Corrigendum] Association between the expression levels of TAZ, AXL and CTGF and clinicopathological parameters in patients with colon cancer

Zhang,Shu‑Dong; McCrudden,Cian M.; Yuen,Hiu‑Fung; Leung,Ka Lai; Hong,Wan‑Jin; Kwok,Hang Fai

doi:10.3892/ol.2016.4464

[Corrigendum] Association between the expression levels of TAZ, AXL and CTGF and clinicopathological parameters in patients with colon cancer

Authors:
- Shu‑Dong Zhang
- Cian M. McCrudden
- Hiu‑Fung Yuen
- Ka Lai Leung
- Wan‑Jin Hong
- Hang Fai Kwok
View Affiliations

Affiliations: Faculty of Health Sciences, University of Macau, Macau, SAR, P.R. China, Center for Cancer Research and Cell Biology, School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, UK, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Proteos, Singapore 138673, Republic of Singapore
Published online on: April 19, 2016 https://doi.org/10.3892/ol.2016.4464
Pages: 3904-3904

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Article

Association between the expression levels of TAZ, AXL and CTGF and clinicopathological parameters in patients with colon cancer

SHU-DONG ZHANG, CIAN M. McCRUDDEN, HIU-FUNG YUEN, KA LAI LEUNG, WAN-JIN HONG AND HANG FAI KWOK

Oncol Lett 11: [Related article:] 1223-1229, 2016; DOI: 10.3892/ol.2015.3999

We wish to inform the readers that the use of protein name ‘Tafazzin’ in the above-mentioned manuscript for TAZ is incorrect. TAZ is already the protein name for TAZ, and WWTR1 (WW domain containing transcription regulator 1) is the gene name for TAZ. We regret any confusion that has arisen as a result of this error.